News

The agency’s conclusions are based on regulatory oversight needed to manage risks associated with CBD and other cannabis-derived products.

Be on the lookout for anti-Semitic messages.

In remembrance of those we lost…

SPL026 with supportive therapy sees positive results in patients with major depressive disorder.

How can recovery-oriented cognitive therapy be a game changer for these individuals?

“We are oceans, not boats.”

Back to the future… or blast to the past?

Are you ready to understand how recovery-oriented cognitive therapy (CT-R) promotes wellness and empowerment for individuals experiencing serious mental health challenges? Check out this CME article.

Catatonia: learn more about how to best diagnose early.

This morning, we mourn the victims of the Monterey Park mass shooting.

From a new FDA approval to treating “New Year depression” in patients, here are highlights from the week in Psychiatric Times.

The FDA has accepted the NDA for nasal nalmefene, OPNT003, to treat opioid overdose.

An organizational psychiatrist discusses the psychology of fraud—and the unique role of psychiatry in helping us better understand it.

Be careful what you take...

"Despite many unanswered questions, Daniel M’Naghten is forever remembered as the man who set a lasting legal precedent."

Is inflammation a biomarker of antidepressant efficacy? Researchers analyzed blood CRP levels as a predictor of response to antidepressants.

“And I know that I no longer have enough in the tank to do justice…”

“Breathing clouds at every turn, We hold what wisdom we must learn.”

Which innovations can improve measurement, technology, investment, and public policy surrounding brain health?

The American Academy of Psychiatry and the Law hosted its first in-person meeting in October 2022. Check out these highlights.

A new era of antiracism could be starting for the Chicago Bears…

"The psychiatrist may be obligated to protect the fetus or warn authorities of the patient’s intent."

There may not be a diagnosis for ‘New Year Depression,’ about 10% to 20% of individuals in the US may get a milder form of these winter blues.

Celebrating 25 years of Poetry of the Times with Richard Berlin, MD!

New approval for schizophrenia and bipolar I disorder.

Psychosocial consequences are common after acquired brain injury and may represent the greatest challenge facing individuals with brain injury. Understanding the psychosocial consequences of brain injury, and the evidenced-based interventions to address those consequences can assist clinicians in providing effective treatment following acquired brain injury.

Is your practice welcoming to those of all races?

In honor of Martin Luther King Jr Day, a psychiatrist reflects on what is needed most—action.

“The sooner you can recognize and diagnose bipolar, the sooner you can institute effective evidence-based treatments.”